AIM IMMUNOTECH INC. Common Stock, Capital Shares Reserved for Future Issuance
AIM IMMUNOTECH INC. (AIM) had Common Stock, Capital Shares Reserved for Future Issuance of 400.00 thousand shares as of 2024-12-31, per its 10-K filed 2025-03-27.
Financial Statements › Notes › Class of Stock Disclosures
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2025-03-27
- 2024-12-31: Common Stock, Capital Shares Reserved for Future Issuance 400.00K shares.
- 2018-12-31: Common Stock, Capital Shares Reserved for Future Issuance 8.90M shares.
- 2018-09-30: Common Stock, Capital Shares Reserved for Future Issuance 8.90M shares.
- 2018-09-12: Common Stock, Capital Shares Reserved for Future Issuance 7.00M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance |
|---|---|
| 2024-12-31 | 400.00K shares 10-K · filed 2025-03-27 |
| 2018-12-31 | 8.90M shares 10-K · filed 2019-04-01 |
| 2018-09-30 | 8.90M shares 10-Q · filed 2018-11-14 |
| 2018-09-12 | 7.00M shares 10-K · filed 2025-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |